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7RESEARCH Open AccessClinical and pharmacokinetic evaluation of
S-ketamine for intravenous general anaesthesia in
horses undergoing field castration
Daniela Casoni1*, Claudia Spadavecchia1, Beat Wampfler2, Wolfgang Thormann3 and Olivier L Levionnois1Abstract
Background: Intravenous anaesthetic drugs are the primary means for producing general anaesthesia in equine
practice. The ideal drug for intravenous anaesthesia has high reliability and pharmacokinetic properties indicating
short elimination and lack of accumulation when administered for prolonged periods. Induction of general anaesthesia
with racemic ketamine preceded by profound sedation has already an established place in the equine field anaesthesia.
Due to potential advantages over racemic ketamine, S-ketamine has been employed in horses to induce general
anaesthesia, but its optimal dose remains under investigation. The objective of this study was to evaluate whether
2.5 mg/kg S-ketamine could be used as a single intravenous bolus to provide short-term surgical anaesthesia in
colts undergoing surgical castration, and to report its pharmacokinetic profile.
Results: After premedication with romifidine and L-methadone, the combination of S-ketamine and diazepam allowed
reaching surgical anaesthesia in the 28 colts. Induction of anaesthesia as well as recovery were good to excellent in the
majority (n = 22 and 24, respectively) of the colts. Seven horses required additional administration of S-ketamine to
prolong the duration of surgical anaesthesia. Redosing did not compromise recovery quality. Plasma concentration of
S-ketamine decreased rapidly after administration, following a two-compartmental model, leading to the hypothesis
of a consistent unchanged elimination of the parent compound into the urine beside its conversion to S-norketamine.
The observed plasma concentrations of S-ketamine at the time of first movement were various and did not support
the definition of a clear cut-off value to predict the termination of the drug effect.
Conclusions: The administration of 2.5 mg/kg IV S-ketamine after adequate premedication provided good quality of
induction and recovery and a duration of action similar to what has been reported for racemic ketamine at the dose
of 2.2 mg/kg. Until further investigations will be provided, close monitoring to adapt drug delivery is mandatory,
particularly once the first 10 minutes after injection are elapsed. Taking into account rapid elimination of S-ketamine,
significant inter-individual variability and rapid loss of effect over a narrow range of concentrations a sudden return of
consciousness has to be foreseen.
Keywords: S-ketamine, Horses, Intravenous anesthesia, Field castration, Plasma level, PharmacokineticBackground
The administration of racemic ketamine and diazepam
following the premedication with an α-2 agonist for pro-
ducing short term anaesthesia represents one of the most
significant events in equine anaesthesia in the last fifty
years [1]. Since its introduction in the early Seventies,* Correspondence: daniela.casoni@vetsuisse.unibe.ch
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unless otherwise stated.racemic ketamine has been gaining hedging popularity
due to its safety and reliability in allowing most surgical
procedures and rapid recoveries. However, undesirable
psychomimetic effects during the emergence from general
anaesthesia have been reported.
Racemic ketamine is the mixture of two enantiomers:
S (+) ketamine and R (−) ketamine: recently, it has been
recognized that each ketamine enantiomer can evoke dif-
ferent effects. In humans, when compared to R- and ra-
cemic ketamine at clinical anaesthetic doses, S-ketamine
was found to evoke shorter and fewer psychomimeticThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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anaesthetic depth the S-enantiomer was associated with a
more rapid recovery of psychomotor skills than the ra-
cemic mixture [3]. Furthermore, a different pharmacoki-
netic profile for the two enantiomers was described in
humans [4] as well as in dogs and ponies [5,6]. The extent
of pharmacokinetic enantioselectivity has been shown to
be species-specific and dependent on drugs concomitantly
administered [7]. If administered alone, S-ketamine has a
higher clearance than in the racemic mixture resulting in
quicker elimination, shorter duration of action and faster
recovery from anaesthesia [4,8,9].
In horses, ataxia, excitation, and residual muscle rigidity
increase the risk for complications during the recovery
phase. Since trained assistance is minimal under field con-
ditions, a single injection of an anaesthetic should ideally
allow for completion of a standard surgical procedure. To
extend the duration of anaesthesia, re-dosing should be
possible, but without compromising its safety and overall
quality. Due to its favorable pharmacological profile, com-
pared to the racemic ketamine, S-ketamine might result in
a smoother quality of induction and in a better quality of
recovery. Data in the literature are still insufficient to de-
termining an appropriate anaesthetic protocol based on
S-ketamine for surgical anaesthesia in horses. Several
studies have shown that the ratio of anaesthetic potency
between S-ketamine and racemic ketamine can be up to
1:3 [10-12]. In dogs, a potency ratio of 1:1.3 has been re-
ported under experimental conditions [13] and 1:1.5 under
clinical conditions [14]. The results from Rossetti et al.
[15] suggested a similar potency ratio in horses. In a previ-
ous clinical trial 2 mg/kg S-ketamine was found by the au-
thors as being insufficient to obtain surgical anaesthesia
(unpublished data).
This study aimed at evaluating whether S-ketamine
could be used as a single bolus to provide short-term
surgical anaesthesia in horses undergoing castration, and
at reporting the pharmacokinetic profile of S-ketamine
and its main active metabolite, S-norketamine. We hy-
pothesized that S-ketamine at 2.5 mg/kg given as a sin-
gle bolus would be appropriate to perform surgical
castration in healthy colts under field conditions.
Methods
This prospective clinical trial was reviewed and approved
by the Committee for Animal Experimentation of the
Canton Bern, Switzerland (BE 11/43).
Study design and animals
Twenty-eight colts of various breeds scheduled for field
castration, and classified as ASA I or II, older than
6 months and weighing more than 200 kg were included
in the study. Weight was calculated in kg via the follow-
ing formula: (girth2× length)/ 11877 [16]. All the animalswere fasted for 6 hours before anaesthesia, but free ac-
cess to the water was granted.
Experimental protocol
After clinical examination and weight assessment, every
horse was premedicated with romifidine at 0.1 mg/kg
(Sedivet® Boehringer Ingelheim, Switzerland) injected in
the right jugular vein. Five to ten minutes after pre-
medication, a 13 G. indwelling catheter (Provet AG/
Petco AG Heiland, Switzerland) was placed in the left
jugular vein. Immediately after catheter placement,
L-methadone/fenpipramide 50/2.5 μg kg−1 IV (Polamivet ®,
Intervet, Switzerland) was administered and the horses
were walked from their box to the induction area. Sedation
quality was scored including response to tactile and audi-
tory stimuli (Table 1) at least 5 minutes after catheter
placement and not more than 30 minutes after romifidine
administration. If the sedation score was higher than 2,
additional romifidine was administered (0.03 mg/kg IV)
and the sedation reassessed after 5 minutes. If the sedation
score remained higher than 2, a third dose (0.015 mg/kg)
was allowed, but if still judged insufficient, the horse would
be excluded from the trial. The overall quality of sedation
achieved was evaluated using a visual analogue scale (VAS)
from 0 (best possible sedation) to 100 mm (worst possible
sedation). Heart rate (HR), pulse rate (PR) and respiratory
rate (RR) were then recorded.
General anaesthesia was induced with diazepam
0.05 mg/kg IV (Valium, Roche, Basel, Switzerland) and
S- ketamine 2.5 mg/kg IV (Keta-S Graeub AG, Bern,
Switzerland) administered in sequence. Anaesthesia on-
set time (T_onset) was defined as the time elapsing from
the end of injection until lateral recumbency and re-
corded. Induction quality was scored (Table 2) and
assessed using a VAS (from 0 corresponding to best in-
duction to 100 mm corresponding to worst induction).
Oxygen was then supplemented (10 L min−1) via a nasal
tube (10 mm ED) introduced in the ventral meatus of
the dependent nostril, up to the lateral canthus of the
eye. In case of apnea lasting for more than 1 minute,
endo-tracheal intubation would be performed and venti-
lation assisted by using a Hudson valve. The time
elapsed between the end of S-ketamine administration (in-
duction) and first surgical incision (T_incision), first
(T_testis_1) and second (T_testis_2) testicle removal, end
of surgery (T_surgery), as well as appearance of brisk pal-
pebral reflex (T_palpebral), first purposeful movement
(T_movement), sternal recumbency (T_sternal) and stand-
ing position (T_standing) was recorded. Lidocaine 2%
(10–15 mL) was injected by the surgeon into the testicle
and the spermatic cord before each testicle had been
emasculated. Depth of anaesthesia was continuously eval-
uated and occurrence of palpebral reflex, blinking, nystag-
mus, sweating, tears production, twitching, ear movement
Table 1 Evaluation of sedation and responsiveness to external stimuli
Parameter Score Description
Sedation score 1 (Profound) Animal stupourous, CTG < 60 cm., severe ataxia
2 (Strong) Animal apathetic, 60 < CTG <80 cm moderate ataxia
3 (Moderate) Animal calm, head lowered between 80 < CTG <100 cm, mild ataxia
4 (Mild) Animal calm, CGT > 100 cm., minimal ataxia
5 (Absent) No apparent sedation
Response to tactile stimulation (Picking the neck) 1 (Absent) No response
2 (Mild) Slow, delayed response
3 (Moderate) Moderate response
4 (Strong) Rapid, marked response
Response to auditory stimulation (Clapping hands) 1 (Absent) No response
2 (Mild) Slow, delayed response
3 (Moderate) Moderate response
4 (Strong) Rapid, marked response
A sedation score of 1 or 2 was mandatory before proceeding to induction of general anaesthesia. CGT = chin-to-ground distance (measured in cm).
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revealed by tail, head or limb movements, or excessive
muscular tension, 1 mg/kg S-ketamine was administered
IV up to 2 times. Thiopental (1–2 mg/kg) was adminis-
tered IV if further deepening was deemed necessary. In
case of increased muscular tone during the surgical pro-
cedure without purposeful movements, 0.02 mg/kg romifi-
dine was administered once IV. All animals were
monitored clinically including recording of PR and RR,
and instrumented (Microcap Plus®, Oridion) with portable
capnography (upper nostril) and pulse oxymetry (tongue)
until sternal recumbency was achieved. All the horses re-
covered without assistance, but with an operator at the
head to prevent uncontrolled movements or escaping. Re-
covery quality was scored (Table 2) and assessed via VASTable 2 Evaluation of the quality of anaesthesia induction, su
Parameter Score Description
Induction score 1 (Excellent) Sinks smoothly to the ground, n
2 (Good) Sinks smoothly to the ground, s
3 (Fair) Inadequate relaxation, forward-b
4 (Poor) Inadequate relaxation, considera
5 (Very poor) Failure to reach recumbency
Recovery score 1 (Excellent) Quiet, 1 or 2 coordinated effort
2 (Good) Quiet, 1 or 2 slightly uncoordina
3 (Fair) Multiple (>2) quiet attempts to
4 (Poor) Multiple (>2) uncoordinated att
5 (Very poor) Recovery resulting in major inju
Surgical score 1 (Excellent) Good muscle relaxation, easy ex
2 (Good) Moderate retraction of the crem
3 (Fair) Difficult extraction of the testicl
4 (Poor) Movements of the horse during(from 0 corresponding to best recovery to 100 mm corre-
sponding to worst recovery). Once the horses recovered a
standing position, HR and RR were recorded. The scores
were always attributed by the same investigator, except the
score for the quality of surgical condition (Table 2) attrib-
uted by the surgeon.Sampling and analytical procedures
Venous blood (10 mL) was sampled from the catheter
and collected in lithium heparinized tubes before the in-
jection of S-ketamine (−2) and at 2, 4, 8, 13 and 20 mi-
nutes after the end of S-ketamine injection. In case of a
second injection of S-ketamine, further samples at 2, 4
and 8 minutes following the reinjection were collected.rgical conditions and recovery phase
o forward-backward movement, no excitement
light forward-backward movement, slight head or limb twitching
ackward movement, visible ataxia, twitching, slight limb paddling
ble movement and ataxia, marked limb paddling
s to sternal and standing positions, minimal to no ataxia once standing
ted efforts to sternal and standing positions, mild ataxia once standing
sternal and standing positions, mild to considerable ataxia once standing
empts to sternal and standing positions
ry
traction of the testicle
aster muscle
e
surgery, reinjection required
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times were allowed and deviations were reported. After
collection, the samples were placed in an isolated pack-
age on ice until centrifugation was performed. Plasma
was frozen at −80°C until the assay was performed. Con-
centrations of S-ketamine and S-norketamine were deter-
mined using enantioselective capillary electrophoresis (CE)
according to the techniques described by Theurillat and
colleagues [17,18] using the extraction procedure described
in Bergadano et al. [19] with phosphoric acid for acidifica-
tion and reconstitution in 1:1 diluted running buffer with-
out chiral selector. The pH 2.5 Tris/phosphate running
buffer contained 2% (w/v) highly sulfated γ-cyclodextrin
(Beckman Coulter, Fullerton, California, USA) as chiral
selector. The limit of quantification (LOQ) was set at
0.5 μM (0.12 μg mL−1).Pharmacokinetic modeling
Each step of the pharmacokinetic modeling was per-
formed with commercially available software (Phoenix™
WinNonlin® 6.2, Pharsight Inc.). Based on data fit, diag-
nostic plots, Akaike information criterion (AIC) and resid-
uals analysis, the most suitable standard mammillary
multi-compartmental model was determined for S-keta-
mine plasma concentrations of each individual. This was
performed in order to obtain initial estimates for the
population modeling. Non-compartmental analysis for S-
ketamine and S-norketamine concentrations were also
performed to orient initial estimates. Then, different
combined parent-metabolite models of the population
pharmacokinetic data were evaluated using different
Non-Linear Mixed Effects algorithms. The model was
firstly fit to the data from the initial single bolus of
S-ketamine in order to determine the best applicable
procedure and the parent-metabolite relationship. The
model was subsequently refined by simultaneously fit-
ting all available concentration-time profiles (including
re-dosing). The final estimates were evaluated based on
data fit, adequacy to initial estimates, diagnostic parame-
ters and residual analysis. Based on the final model, a
simulation for maintaining steady state concentration
for S-ketamine was carried out, targeting a plasma con-
centration compatible with the maintenance of surgical
level of anaesthesia.Statistical analysis
The SigmaStat 3.5 (Point Richmond, CA, USA) software
package was used to perform statistical evaluation and
significance was reached at P = 0.05. Due to the small
number of sampling, all the data are presented as me-
dian and IQR independently of their distribution.
Effect of time on PR and RR was tested with one way
ANOVA test in RANK for repeated measures. Spearmanrank order test was used to test: 1) correlations between
quality of sedation, induction and recovery (score and
VAS) in all horses (n = 28) and in the horses that did not
receive any additional drug during the procedure (n = 20);
2) correlation between time at which clinical signs of light-
ening of anaesthesia appeared and duration of anaesthesia;
3) correlation between T_movement and predicted plasma
concentrations of S-ketamine at T_movement in all
horses that did not move before the end of surgery; 4) cor-
relation between T_movement and the area under the
curves of the predicted concentration of S-ketamine
against time from 2 to 20 minutes (AUC S-k 2–20).
Differences of measured S-ketamine plasma concen-
trations at 2, 4, 8 minutes after administration between
the horses receiving one or two boluses were tested by a
2 way-ANOVA test for repeated measures.
Results
Clinical results
Twenty-eight colts with a median age of 30 months
(IQR 24–42) and a median weight of 453 kg (IQR 386.5-
510.5) were anaesthetized and castrated. An adequate
sedation score (<3) was reached after the first administra-
tion of romifidine in 17 horses (61%), as judged at a me-
dian time of 23 minutes (IQR 20.25-27) after injection.
One additional injection of romifidine was required by 9
horses (32%) and two by 2 horses (7%). Median T_onset
was 50.5 seconds (IQR 45–57). Median induction score
was 1.5 (IQR 1–2, maximum 4) where 14 horses were
scored 1 (excellent), 8 horses were scored 2 (good), 5
horses were scored 3 (fair) and 1 horse (Horse #13) was
scored 4 (poor). Median VAS for quality of induction was
14 mm (IQR 7.5-35.5, maximum 76).
For all the horses but one (horse #24), removal of the
first testis (9.5 minutes, IQR 8–11.3) was possible with a
single administration of S-ketamine. Twenty-one horses
(75%) did not require additional S-ketamine until the
end of the procedure and the T_movement was 25 mi-
nutes (IQR, 22.5-29.5). An additional bolus (1 mg/kg)
was required by 7 horses at a median time of 13.5 mi-
nutes (IQR, 11.8-14.5) after movement occurred at
12.6 minutes (IQR, 11.5-14.5). Two horses (horses #17
and #24) required supplemental S-ketamine because of
delayed surgery due to technical difficulties, in particular
in horse #24 the extraction of the first testis was per-
formed in 18.6 minutes. Five other horses required the
second bolus during removal of the second testis. None of
the horses whose exteriorization of the second testis was
terminated in less than 12.5 minutes (n = 17, T_testis_2 of
12.6 minutes IQR, 11–13) required additional S-ketamine.
In 2 horses, muscle relaxation was judged insufficient
(horses #13 and #24) and an additional bolus of romifidine
was administered intra-operatively. Horse #24 was the
only horse requiring 2 additional boluses of S-ketamine
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was attributed to the 7 horses that required additional
intra-operative S-ketamine, while a score of 1 (excellent)
was attributed to 17 horses, and of 2 (good) to 4 horses.
Timing of the different anaesthetic events is presented in
Table 3 and Figure 1. Apnea lasting longer than 60 seconds
was never observed, and emergency intubation was never
required.
Among the clinical signs associated with recovery
from general anaesthesia, only the reappearance of a
strong palpebral reflex was repeatedly observed (n = 25).
Among the 20 horses that during anaesthetic time did
not receive any supplemental drug, a strong palpebral re-
flex appeared in 19 of them (95%) at a median time of
14 minutes (IQR 10.5-15) after induction of anaesthesia.
Nystagmus was observed at the beginning of anaesthesia in
2 horses, when the testicles were pulled in 2 other horses,
and during the whole surgical procedure in 3 horses.
Pulse-oxymetry was functioning in 8 horses only. The
lowest observed SpO2 value was 92%. After sedation, the
PR was significantly lower (P < 0.001) than the baseline,
decreasing from 39 (IQR 36–42), to 28 (IQR 24–32) per
minute. After induction, the PR returned to initial values
within 10 minutes. The RR did not vary after sedation (me-
dian value of 14, IQR 13–16), but decreased significantly
after induction (median value of 11, IQR 7–17.5) and pro-
gressively increased over baseline values after 18 minutes
of general anaesthesia (median 20, IQR 14–28.5).
During recovery from general anaesthesia, sternal re-
cumbency was extremely short (or absent) in 18 horses
(65% of all horses). The median VAS for quality of re-
covery was 9.5 mm (IQR 5–24.5) with 18 horses scored
as 1 (excellent), 6 horses as 2 (good), 2 horses as 3 (fair),
and 1 horse as 4 (poor). None of the horses got injured
during the recovery. Within the 7 horses which required
additional S-ketamine, 4 horses were scored as 1 (excel-
lent), 1 horse as 2 (good), and 1 horse as 3 (fair). Neither
the induction score nor the recovery score correlated to
the sedation score, but the recovery score was positivelyTable 3 Time (minutes) elapsed between the end of S-ketami
events
Group 1
Parameters Median (IQR) Range [Min-M
T_palpebral 14 (10.5–14.7) [8–20]
T_surgery 15 (13–16.5) [11–18.6]
T_movement 25 (22.5–29.5) [16.2–41.2]
T_sternal 28.8 (26–34.2) [20–42.7]
T_standing 32.6 (26–37.2) [20–49]
“Group 1” (n = 20) horses that received a single injection of S-ketamine.
“Group 2” (n = 7) horses that received additional injection(s) of S-ketamine during t
T_palpebral: Time from anaesthesia induction until appearance of a brisk palpebral
surgical procedure; T_movement: Time from anaesthesia induction until appearanc
sternal position; T_standing: Time from anaesthesia induction until return to standincorrelated to the induction score (P < 0.03). The same
results were found analyzing the VAS.
Pharmacokinetic results
The concentration for S-ketamine at 2 min after bolus ad-
ministration (samples drawn between 2.0 and 2.6 minutes)
varied between 2.61 and 20.07 μg mL−1 (mean ± SD: 7.01 ±
3.51 μg mL−1). Thereafter, the S-ketamine concentration
decreased rapidly in all individuals and reached 0.48 to
2.42 μg mL−1 (1.15 ± 0.45 μg mL−1) at 8 minutes after ad-
ministration (Figure 2). S-norketamine was already ob-
served at the first sampling time; the metabolite reached
peak concentration at 4 minutes (second time point,
0.88 ± 0.27 μg mL−1) in 14 horses and at 8 minutes (third
time point, 0.86 ± 0.28 μg mL−1) in the other 14 individuals.
S-ketamine and S-norketamine concentration curves
are graphically depicted in Figure 2. Early plasma con-
centrations for S-ketamine were not significantly differ-
ent between horses receiving a single bolus and those
requiring redosing (Figure 2).
Due to S-ketamine re-administration in 7 horses, plasma
concentrations below the LOQ in several horses, or miss-
ing samples, individual multi-compartmental modeling
could be obtained only for 15 horses. For all these individ-
uals, the time course of S-ketamine concentration was
best represented by a two-compartmental model with 1/Ŷ
as weighing factor. The one compartment model failed to
capture the elimination phase of S-ketamine concentra-
tion profiles (data not shown). To describe the production
of S-norketamine, the model illustrated in Figure 3 was
chosen after having tested several elimination pathways
and compartment arrangements. The final population par-
ameter estimates were obtained using the iterative-2-stage
method and are listed in Table 4. The fit of the prediction
model to the observation data is represented in Figure 2
for horses receiving a single bolus (a.,b.) as well as for
those requiring redosing (c.,d.).
Surgical anaesthesia tended to end between 10 and 13 mi-
nutes after bolus administration. At 8 minutes medianne administration and the occurrence of significant
Group 2
ax] Median (IQR) Range [Min-Max]
10 (9–16) [7–20]
18.6 (15–19.8) [14.9–23]
12.6 (11.5–14.5) [10.5–17]
30 (26.9–36) [24–39.2]
32.9 (30.6–39) [27–40]
he procedure.
reflex; T_surgery: Time from anaesthesia induction until termination of the
e of first movement; T_sternal: Time from anaesthesia induction until return to
g position.
Figure 1 Occurrence of events after anaesthesia induction in horses that received only one bolus of S-ketamine. Time is expressed as median and
10%-25%-75%-90% interquartiles; dots represent the outsiders. Number of horses in which each event was registered is reported besides. T_palpebral:
Time from anaesthesia induction until appearance of a brisk palpebral reflex; T_surgery: Time from anaesthesia induction until termination of the
surgical procedure; T_movement: Time from anaesthesia induction until appearance of first movement; T_sternal: Time from anaesthesia induction until
return to sternal position; T_standing: Time from anaesthesia induction until return to standing position.
Figure 2 Plasma concentrations over time of S-ketamine (a., c.) and S-norketamine (b., d.). The circles represent the measured concentrations for
S-ketamine (a., c.) and S-norketamine (b., d.) in horses administered S-ketamine only once (n = 21; a., b.), or twice (n = 7; c., d.). In each figure, the
continuous lines represent the respective predicted concentrations for S-ketamine or S-norketamine as obtained by the final population pharmacokinetic
model (a., b.: graph with mean data of 15 horses as described in Section 3.2; c., d.: individual graphs for the 7 horses).
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Figure 3 Parent-metabolite pharmacokinetic model for S-ketamine and S-norketamine. V1: Volume of the central compartment; Cl1: Clearance
from the central compartment; V2: Volume of the peripheral compartment; Cl2: Clearance from the peripheral compartment; ClParMet: Clearance
from S-ketamine to S-norketamine.
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(IQR 3.69-5.88) and 4.14 μg mL−1 (IQR 3.37-6.21) in the
horses receiving one and two boluses, respectively. The
predicted average S-ketamine plasma concentrations were
2 μg mL−1 at 6 minutes and 1 μg mL−1 at 8.5 minutes after
a single IV bolus of 2.5 mg/kg. Therefore, it was consideredTable 4 Final population pharmacokinetic parameters
Pk paramaters S-ketamine S-norketamine
V1 (mL/kg) 132.7 59.9
Cl1 (mL/kg/min) 36.3 30
V2 (mL/kg) 376.3
Cl2 (mL/kg/min) 14.9
ClParMet (mL/kg/min) 21.1
t1/2 (min) 8.5 8.6
Cltot (mL/kg/min) 44.5
Vss (mL/kg) 191.4
AUC (μg/min/mL) 56.2 16.2
AUMC (μg/min2/mL) 241.6 272.5
MRT (min) 4.3 16.82
Cmax (μg/mL) 0.8
Tmax (min) 7.4
V1: Volume of the central compartment; Cl1: Clearance from the central
compartment; V2: Volume of the peripheral compartment; Cl2: Clearance from
the peripheral compartment; ClParMet: Clearance from S-ketamine to S-norketamine;
t1/2: Elimination half-life; Cltot: Total body clearance; Vss: Volume of distribution at
steady-state; AUC: Area under the time course curve; AUMC: Area under the
moment of the time course curve; MRT: Mean residence time; Cmax: Maximum
concentration; Tmax: Time at maximum concentration.that maintenance of S-ketamine plasma concentration at
least between 1.5 and 2 μg mL−1 is required for mainten-
ance of surgical anaesthesia. Estimated elimination half-
time at steady state was 2.25 minutes.
In horses not requiring the second bolus, median con-
centration of S-ketamine was predicted to be 0.15 (IQR
0.06-0.31) μg mL−1 at T_movement, and a significant
negative correlation was found between S-ketamine con-
centration measured at T_movement and the time of
movement (rs -0.665 with p = .005). However the values
of T_movement did not correlate with the AUC S-k2–20.
Discussion
As hypothesized, S-ketamine administered at 2.5 mg/kg
allowed to reach surgical anaesthesia in all horses, and
induction of anaesthesia was good to excellent in the
large majority of the animals. However, in 5 horses
(18%), surgical castration could not be completed with-
out the administration of a second S-ketamine bolus
despite the absence of surgical complications. As the
total body weight was predicted using Carroll and Hun-
tington formula, the dose of S-ketamine could have been
underestimated in these five horses but their S-ketamine
plasma concentrations did not differ significantly from
the horses that did not require the second bolus. It is in-
teresting to underline that in the group of horses not re-
quiring additional S-ketamine, the noxious stimulation
was terminated within 12.5 minutes, while, when the nox-
ious stimulation was still ongoing at 12.5 minutes, the
horses showed very rapidly signs of awakening and
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that 2.5 mg/kg S-ketamine IV allowed for a mean duration
of surgical anaesthesia of 12 minutes. The duration of an-
aesthesia observed in the present study is similar to that
reported after administration of 2.2 mg/kg racemic keta-
mine IV in horses under experimental conditions [20] and
in ponies undergoing field castration [21].
The dose of 2.5 mg/kg was selected based on a previous
trial (unpublished data) indicating that 2 mg/kg appeared
to be insufficient to maintain surgical anaesthesia for cas-
tration. Rossetti et al. [15] also reported that re-dosing
was necessary at the latest 7 minutes after induction of an-
aesthesia when 2 mg/kg S-ketamine IV was administered
under similar conditions. Such a short effect would not
have allowed for performing the whole surgical procedure
with a single bolus and, therefore, this dose was consid-
ered insufficient for meeting the objective of the present
study. Rossetti et al. [15] hypothesized that occasional
poor anaesthesia induction, earlier recumbency and the
presence of minor excitatory effects after S-ketamine in-
duction could have been the result of slight overdose;
however, in one horse, a second dose of S-ketamine was
required to obtain recumbency. In the present study, short
induction times were not associated with poor induction
quality, neither with excitatory effects (observed in only
one horse). Therefore, an increase of induction dose to
2.5 mg/kg IV can be safely suggested when a surgical
depth of anaesthesia has to be maintained for longer than
10 minutes.
Further administration of S-ketamine did not comprom-
ise either surgery or recovery quality. While the duration
of a surgical depth of anaesthesia was prolonged for
horses receiving a second bolus of S-ketamine (1 mg/kg),
the time between induction of general anaesthesia and
standing position was not significantly longer.
During the trial, pulse oximetry had high incidence of
failure. Presence of sunlight, potential peripheral vaso-
constriction and hypertension, recorded irregularities in
the heart rhythm could explain its poor function; thus,
ensuring clinical monitoring and oxygen supplementa-
tion was deemed essential in the present trial.
The pharmacokinetic profiles of ketamine and S-
ketamine have been characterized in previous studies as
being based on one-, two- or three compartments [22-24].
In the present investigation, as in others [25-28] the time
course of S-ketamine was clearly at least bi-exponential in
all individuals, and the addition of a third compartment
did not improve significantly the diagnostic plots, increas-
ing the AICs. However, in several horses the number of
samples was insufficient to characterize a tri-exponential
curve. The limited sampling time was due to technical
reasons, namely the difficulty to perform further blood
collection at fixed time points during recovering from
general anaesthesia in field conditions. Moreover, the lastmeasured plasma concentrations approximated the LOQ,
therefore further samples could not have guaranteed gath-
ering pharmacokinetic information. The small amounts of
time points over a short time do not allow characterizing
adequately the presence of a third compartment and the
estimation of a terminal half-time. Simultaneously, a sin-
gle compartment was sufficient to model the concentra-
tion profile of S-norketamine. In two previous studies
applying a parent-metabolite model to characterize keta-
mine and its metabolites [28,29], the only possible elimin-
ation pathway given for ketamine was the production of
norketamine without direct elimination from the central
compartment. In the present study, the addition of a dir-
ect clearance pathway for S-ketamine from its central
compartment beside conversion to S-norketamine im-
proved the model fit for both compounds, supporting the
rapid elimination of S-ketamine unchanged in urine, as
already largely documented in equine and in other species
for ketamine [18,30]. In the previous literature, different
models of norketamine conversion were applied: Lankveld
et al. [28] modeled the conversion of norketamine from
the central compartment while Herd and colleagues [24]
applied additional intermediate compartments to account
for the transit time between ketamine clearance and nor-
ketamine production. In the present study, conversion to
S-norketamine from the peripheral compartment ap-
peared a simple method improving data fit and avoiding
over-parameterization. Despite differences in model struc-
tures and study design, the overall pharmacokinetic pa-
rameters for volume of distribution and clearance were
similar to previous studies [6,7,28,31]. However, pharma-
cokinetic investigations including larger populations under
different settings are still required before it will be possible
to generalize the pharmacokinetic profile of S-ketamine
and its metabolites in horses.
Waterman and colleagues [26] proposed that after a
bolus of 2.2 mg/kg racemic ketamine, horses may return to
consciousness at a ketamine concentration of 1 μg mL−1.
In the present study, levels of anaesthesia became incom-
patible with surgical procedure at S-ketamine concentra-
tion close to 1 μg mL−1 and signs of arousal (estimated
around 13 minutes when no bolus was re-administered)
occured close to 0.6 μg ml−1. However, the variability of
the observed plasma concentrations of S-ketamine at
T_movement and its correlation to anaesthesia duration
do not support the definition of a clear cut-off value to pre-
dict the termination of the effect.
According to the pharmacokinetic simulation, in order
to maintain surgical level of anaesthesia with S-ketamine
administered at constant rate infusion, an infusion
around 70 μg kg−1 min−1 has to be started immediately
after the induction of anaesthesia. However, until further
investigations will be provided, close monitoring to
adapt drug delivery is mandatory, taking into account
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variability and the rapid loss of effect over a narrow
range of concentrations. Marntell et al. [32] reported
that premedication and quality of sedation can influence
the duration of dissociative anaesthesia for short surgical
procedures. In the present study, a dosage of romifidine
between 0.1 and 0.145 mg/kg was administered to target
an appropriate and comparable quality of sedation for all
horses. It is likely that reducing the manipulations be-
tween sedation and induction, a lower dose of romifidine
could be used in some animals; however, due to the
frantic temperament of most colts, an intravenous cath-
eter could not have been placed before sedation in the
majority of the animals. According to Kerr et al. [19],
the duration of anaesthesia after a combination of keta-
mine and diazepam is prolonged if romifidine instead of
xylazine is administered in premedication. The use of
romifidine appears a reasonable suggestion for pre-
medication when the effect of the anaesthetic drug is
short, as for S-ketamine. Moreover, the long sedative ef-
fects achieved with romifidine [33] represent an advan-
tage when the interval between sedation and induction
cannot be standardized. The association of alpha 2 ago-
nists and opioids has already demonstrated a synergistic
effect in clinical and experimental models without an in-
crease in adverse effects from the single drugs [34-38].
Thus, it seems unlikely that a different premedication
(based on current drugs routinely used for pre-
anaesthetic sedation in horses) would be able to further
increase the duration of anaesthesia after 2.5 mg/kg IV
S-ketamine.
In the present study, the only clinical sign occurring
previous to the first movement in a majority of horses
was the return of a brisk palpebral reflex. Arousal signs
were otherwise minimal. When the surgical procedure
lasted longer than 13 minutes, noxious stimulation trig-
gered the recovery and purposeful movements occurred
suddenly.
Conclusions
The administration of 2.5 mg/kg IV S-ketamine after ad-
equate premedication provided good quality of induction
and recovery and a duration of action similar to racemic
ketamine at the dose of 2.2 mg/kg. The short duration
of surgical anaesthesia promoted by the single injection
of S-ketamine might be insufficient to complete surgical
castration. Taking into account the pharmacologic be-
havior of S-ketamine, namely the rapid elimination and
the rapid loss of effect over a narrow range of concentra-
tions, a sudden return of consciousness has to be then
foreseen once the first 10 minutes after injection are
elapsed. Therefore, if the surgical procedure is not ter-
minated yet, need for redosing has to be expected 10 to
15 minutes after injection.Consent
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patients ‘owners for the publication of this report and
any accompanying images.
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